Identification of a novel nicotinic binding site in mouse brain using [125I]‐epibatidine
Tóm tắt
[125I]‐Epibatidine binds to multiple nicotinic acetylcholine receptor (nAChR) subtypes with high affinity. In this study, [125I]‐epibatidine was used to label and characterize a novel nAChR subtype found in mouse brain inferior colliculus, interpeduncular nucleus, and olfactory bulb homogenates. Binding of [125I]‐epibatidine was saturable and apparently monophasic in each brain region ( The sites with lower agonist affinity comprised 30.0±2.2, 58.6±0.1 and 48.7±3.3% of specific [125I]‐epibatidine (200 p The affinity difference between A85380‐sensitive and ‐resistant binding sites was particularly marked (approximately 1000 fold). Thus A85380 was used to differentiate agonist‐sensitive and ‐resistant sites. The pharmacological profiles of the A85380‐resistant sites in each region were assessed with inhibition binding experiments, using 14 agonists and five antagonists. The profiles were indistinguishable across regions, implying that A85380‐resistant [125I]‐epibatidine binding sites in inferior colliculus, interpeduncular nucleus, and olfactory bulb represent a single nAChR subtype. The pharmacological profile of the A85380‐resistant sites is very different from that previously reported for high affinity (−)‐[3H]‐nicotine‐, [125I]‐α‐bungarotoxin‐, or [125I]‐α‐conotoxin MII‐binding sites, suggesting that they represent a novel nAChR population in mouse brain.
Từ khóa
Tài liệu tham khảo
BADIO B., 1994, Epibatidine: a potent analgetic and nicotinic agonist, Mol. Pharmacol., 45, 563
DAVILA‐GARCIA M.I., 1997, [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors, J. Pharmacol. Exp. Ther., 282, 445
DECKER M.W., 1998, Neuronal Nicotinic Receptors, Pharmacology and Therapeutic Opportunities, 395
FLORES C.M., 1996, Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of α3β4, a novel subtype in the mammalian nervous system, J. Neurosci., 16, 7894, 10.1523/JNEUROSCI.16-24-07892.1996
FLORES C.M., 1992, A subtype of nicotinic cholinergic receptor in the brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment, Mol. Pharmacol., 41, 31
HOUGHTLING R.A., 1995, Characterization of [3H]epibatidine binding to nicotinic receptors in rat and human brain, Mol. Pharmacol., 48, 280
MARKS M.J., 1998, Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain, J. Pharmacol. Exp. Ther., 285, 377
PERRY D.C., 1995, [3H]Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study, J. Pharmacol. Exp. Ther., 275, 1030
SEGUELA P., 1992, Molecular cloning, functional properties and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium, J. Neurosci., 13, 596, 10.1523/JNEUROSCI.13-02-00596.1993
SIMMONS D.M., 1989, A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single‐stranded RNA probes, J. Histotechnol, 12, 169, 10.1179/014788889794651870
WHITEAKER P., 2000, 125I‐α‐Conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain, Mol. Pharmacol., 57, 913